Department of Clinical and Experimental Medicine, University of Verona, Verona, Italy.
J Proteomics. 2010 Jan 3;73(3):527-36. doi: 10.1016/j.jprot.2009.08.003. Epub 2009 Aug 13.
Hepcidin, a liver peptide hormone, is the central regulator of iron homeostasis. Hepcidin synthesis is modulated by iron stores, so that iron repletion increases its levels to prevent pathological overload, while iron deficiency strongly inhibits hepcidin to allow an increase in iron absorption from duodenal cells. The emerging pivotal role of hepcidin in iron homeostasis, along with its important links with basic pathways like inflammation, makes the availability of an accurate hepcidin assay as a potentially powerful investigative tool to improve our understanding as well as our diagnostic/prognostic capabilities in many human diseases. There has been a great interest worldwide in developing a reliable and widely applicable assay of the hormone in biological fluids. Being optimal for low-molecular-weight biomarkers, SELDI-TOF-MS has emerged as a valid tool for hepcidin assay. Here we review recent results obtained with this technique, as well as with other Mass Spectrometry-based and immunological methods.
亚铁整合素(Hepcidin),一种肝脏分泌的肽类激素,是铁稳态的中枢调节因子。亚铁整合素的合成受铁储存量的调控,因此铁的补充会增加其水平,以防止病理性过载,而缺铁则会强烈抑制亚铁整合素,从而增加十二指肠细胞对铁的吸收。亚铁整合素在铁稳态中的关键作用,以及它与炎症等基本途径的重要联系,使得能够准确检测亚铁整合素作为一种潜在的强大研究工具,以提高我们对许多人类疾病的理解以及诊断/预后能力。全世界都对开发可靠且广泛适用于生物液体中激素的检测方法产生了浓厚的兴趣。SELDI-TOF-MS 作为一种适用于低分子量生物标志物的方法,已经成为亚铁整合素检测的有效工具。本文综述了该技术以及其他基于质谱和免疫学方法的最新研究结果。